Care of diabetes in children and adolescents: Controversies, changes, and consensus

The Lancet

Volumn 385, Issue 9982, 2015, Pages 2096-2106

  Cameron, Fergus J ^a   Wherrett, Diane K ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; LONG ACTING INSULIN; METFORMIN; SHORT ACTING INSULIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT DISEASE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CHILD CARE; CHILDHOOD DISEASE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; LIFESTYLE MODIFICATION; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TREATMENT PLANNING; ADOLESCENT; CHILD; CONSENSUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; INCIDENCE; LIFE EXPECTANCY; PHARMACEUTICS; PREVALENCE; TRENDS;

ADOLESCENT; CHILD; CONSENSUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; LIFE EXPECTANCY; PREVALENCE; TECHNOLOGY, PHARMACEUTICAL;

EID: 84930080917     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60971-0     Document Type: Review

References (107)

1. C Patterson, L Guariguata, G Dahlquist, G Soltész, G Ogle, M Silink Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes Diabetes Res Clin Pract 103 2014 161 175
2. CC Patterson, GG Dahlquist, E Gyürüs, A Green, G Soltész the EURODIAB Study Group Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study Lancet 373 2009 2027 2033
3. D Dabelea, EJ Mayer-Davis, S Saydah et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009 JAMA 311 2014 1778 1786
4. V Harjutsalo, R Sund, M Knip, P-H Groop Incidence of type 1 diabetes in Finland JAMA 310 2013 427 428
5. Y Berhan, I Waernbaum, T Lind, A Möllsten, G Dahlquist the Swedish Childhood Diabetes Study Group Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden Diabetes 60 2011 577 581
6. DJ Pettitt, J Talton, D Dabelea et al. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study Diabetes Care 37 2014 402 408
7. S Amed, HJ Dean, C Panagiotopoulos et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study Diabetes Care 33 2010 786 791
8. S Fazeli Farsani, MP van der Aa, MMJ van der Vorst, CAJ Knibbe, A de Boer Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches Diabetologia 56 2013 1471 1488
9. Writing Group for the SEARCH for Diabetes in Youth Study D Dabelea, RA Bell et al. Incidence of diabetes in youth in the United States JAMA 297 2007 2716 2724
10. P Zeitler, J Fu, N Tandon et al. Type 2 diabetes in the child and adolescent Pediatr Diabetes 15 suppl 20 2014 26 46
11. R Kanakatti Shankar, C Pihoker, LM Dolan et al. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study Pediatr Diabetes 14 2013 174 180
12. C Pihoker, LK Gilliam, S Ellard et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth J Clin Endocrinol Metab 98 2013 4055 4062
13. MA Atkinson, GS Eisenbarth, AW Michels Type 1 diabetes Lancet 383 2014 69 82
14. 1c predicts time to diagnosis of type 1 diabetes in children at risk Diabetes 2014 10.2337/db14-0497 published online Dec 18.
15. JM Sosenko, JS Skyler, J Mahon et al. Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes Diabetes Care 37 2014 979 984
16. V Parikka, K Näntö-Salonen, M Saarinen et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk Diabetologia 55 2012 1926 1936
17. AG Ziegler, M Rewers, O Simell et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children JAMA 309 2013 2473 2479
18. S Arif, P Leete, V Nguyen et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes Diabetes 63 2014 3835 3845
19. NG Morgan, SJ Richardson Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol Metab 25 2014 611 619
20. E D'Adamo, S Caprio Type 2 diabetes in youth: epidemiology and pathophysiology Diabetes Care 34 suppl 2 2011 S161 S165
21. TODAY Study Group P Zeitler, K Hirst et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes N Engl J Med 366 2012 2247 2256
22. TODAY Study Group Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY Diabetes Care 36 2013 1749 1757
23. O Pinhas-Hamiel, LM Dolan, PS Zeitler Diabetic ketoacidosis among obese African-American adolescents with NIDDM Diabetes Care 20 1997 484 486
24. D Dabelea, A Rewers, JM Stafford et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study Pediatrics 133 2014 e938 e945
25. O Rubio-Cabezas, S Ellard Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options Horm Res Paediatr 80 2013 137 146
26. KC Copeland, J Silverstein, KR Moore et al. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents Pediatrics 131 2013 364 382
27. TJ McDonald, S Ellard Maturity onset diabetes of the young: identification and diagnosis Ann Clin Biochem 50 2013 403 415
28. JA Usher-Smith, M Thompson, A Ercole, FM Walter Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review Diabetologia 55 2012 2878 2894
29. K Lokulo-Sodipe, RJ Moon, JA Edge, JH Davies Identifying targets to reduce the incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in the UK Arch Dis Child 99 2014 438 442
30. M Vanelli, G Chiari, S Lacava, B Iovane Campaign for diabetic ketoacidosis prevention still effective 8 years later Diabetes Care 30 2007 e12
31. H Bui, T To, R Stein, K Fung, D Daneman Is diabetic ketoacidosis at disease onset a result of missed diagnosis? J Pediatr 156 2010 472 477
32. M Fritsch, E Schober, B Rami-Merhar et al. Diabetic ketoacidosis at diagnosis in Austrian children: a population-based analysis, 1989-2011 J Pediatr 163 2013 1484 1488 e1.
33. BR King, NJ Howard, CF Verge et al. A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes Pediatr Diabetes 13 2012 647 651
34. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
35. CE de Beaufort, PG Swift, CT Skinner et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes Diabetes Care 30 2007 2245 2250
36. ML Marcovecchio, J Woodside, T Jones et al. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments Diabetes Care 37 2014 805 813
37. JA McKnight, SH Wild, MJ Lamb et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison Diabet Med 2014 10.1111/dme.12676 published online Dec 15.
38. I Redon, J Beltrand, D Martin et al. Changes in insulin therapy regimens over 10 yr in children and adolescents with type 1 diabetes attending diabetes camps Pediatr Diabetes 15 2014 329 335
39. FJ Cameron, C de Beaufort, HJ Aanstoot et al. Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach Pediatr Diabetes 14 2013 473 480
40. CE de Beaufort, K Lange, PG Swift et al. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009 Pediatr Diabetes 14 2013 422 428
41. 1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37 539 patients between 1995 and 2012 PLoS Med 11 2014 e1001742
42. SM O'Connell, MN Cooper, MK Bulsara, EA Davis, TW Jones Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009 Diabetes Care 34 2011 2379 2380
43. J Rosenbauer, A Dost, B Karges et al. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria Diabetes Care 35 2012 80 86
44. WT Cefalu, RE Ratner The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving! Diabetes Care 37 2014 5 7
45. American Diabetes Association Children and adolescents Diabetes Care 38 suppl 1 2015 S70 S76
46. SJ Brink How to apply the experience from the diabetes control and complications trial to children and adolescents? Ann Med 29 1997 425 438
47. RW Holl, PG Swift, HB Mortensen et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group Eur J Pediatr 162 2003 22 29
48. EA Gale, JS Yudkin Commentary: Politics of affordable insulin BMJ 343 2011 d5675
49. ML Misso, KJ Egberts, M Page, D O'Connor, J Shaw Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus Cochrane Database Syst Rev 2010 CD005103.
50. TC Skinner, FJ Cameron Improving glycaemic control in children and adolescents: which aspects of therapy really matter? Diabet Med 27 2010 369 375
51. DM Maahs, JM Hermann, SN DuBose et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries Diabetologia 57 2014 1578 1585
52. K Doggen, N Debacker, D Beckers et al. Care delivery and outcomes among Belgian children and adolescents with type 1 diabetes Eur J Pediatr 171 2012 1679 1685
53. K Dovc, SS Telic, L Lusa et al. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis Diabetes Technol Ther 16 2014 33 40
54. E Cummins, P Royle, A Snaith et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation Health Technol Assess 14 11 2010 iii iiv xi-xvi, 1-181.
55. NICE Guidance on the use of long-acting insulin analogues for the treatment of diabetes - insulin glargine: technology appraisal no 53 2005 National Institute for Clinical Excellence London
56. ME Craig, SM Twigg, KC Donaghue et al. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults 2011 Australian Government Department of Health and Ageing Canberra
57. K Rebrin, GM Steil, WP van Antwerp, JJ Mastrototaro Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring Am J Physiol 277 1999 E561 E571
58. D Deiss, J Bolinder, JP Riveline et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring Diabetes Care 29 2006 2730 2732
59. IB Hirsch, J Abelseth, BW Bode et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study Diabetes Technol Ther 10 2008 377 383
60. WV Tamborlane, RW Beck, BW Bode et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes N Engl J Med 359 2008 1464 1476
61. T Battelino, I Conget, B Olsen et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial Diabetologia 55 2012 3155 3162
62. RM Bergenstal, WV Tamborlane, A Ahmann Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes N Engl J Med 363 2010 311 320
63. S Weinzimer, D Xing, M Tansey et al. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy Pediatr Diabetes 10 2009 91 96
64. M Phillip, T Danne, S Shalitin et al. Use of continuous glucose monitoring in children and adolescents (∗) Pediatr Diabetes 13 2012 215 228
65. DAFNE Study Group Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial Diabet Med 20 suppl 3 2003 4 5
66. K Price, J Knowles, J Freeman, JK Wales KICk-OFF Study Group Improving outcomes for adolescents with type 1 diabetes: results from the Kids In Control OF Food (KICk-OFF) trial Pediatr Diabetes 14 suppl 18 2013 34
67. KJ Bell, AW Barclay, P Petocz, S Colagiuri, JC Brand-Miller Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis Lancet Diabetes Endocrinol 2 2014 133 140
68. I Rabbone, AE Scaramuzza, MG Ignaccolo et al. Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study Diabetes Res Clin Pract 103 2014 388 394
69. EA Gale, SD Beattie, J Hu, V Koivisto, MH Tan Recruitment to a clinical trial improves glycemic control in patients with diabetes Diabetes Care 30 2007 2989 2992
70. T Heise, L Nosek, BB Ronn et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes Diabetes 53 2004 1614 1620
71. T Wysocki, MA Harris, K Wilkinson, M Sadler, N Mauras, NH White Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes Diabetes Care 26 2003 2043 2047
72. BJ Anderson, L Vangsness, A Connell, D Butler, A Goebel-Fabbri, LM Laffel Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes Diabet Med 19 2002 635 642
73. AM Delamater, M de Wit, V McDarby, J Malik, CL Acerini Psychological care of children and adolescents with type 1 diabetes Pediatr Diabetes 15 suppl 20 2014 232 244
74. DB Petitti, GJ Klingensmith, RA Bell et al. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study J Pediatr 155 2009 668 672 e1-3.
75. AB Dart, PJ Martens, C Rigatto, MD Brownell, HJ Dean, EA Sellers Earlier onset of complications in youth with type 2 diabetes Diabetes Care 37 2014 436 443
76. J Karres, V Pratt, J-M Guettier et al. Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes Diabetes Care 37 2014 2665 2667
77. R Broe, ML Rasmussen, U Frydkjaer-Olsen et al. The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: the Danish cohort of pediatric diabetes 1987 (DCPD1987) Acta Diabetol 51 2014 413 420
78. T Almdal, K Nörgaard, B Feldt-Rasmussen, T Deckert The predictive value of microalbuminuria in IDDM. A five-year follow-up study Diabetes Care 17 1994 120 125
79. G Pambianco, T Costacou, D Ellis, DJ Becker, R Klein, TJ Orchard The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience Diabetes 55 2006 1463 1469
80. BE Klein, CE Myers, KP Howard, R Klein Serum lipids and proliferative diabetic retinopathy and macular edema in persons with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy JAMA Ophthalmol 2014 10.1001/jamaophthalmol.2014.5108 published online Dec 1.
81. DM Nathan, B Zinman, PA Cleary et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005) Arch Intern Med 169 2009 1307 1316
82. TJ LeCaire, M Palta, R Klein, BE Klein, KJ Cruickshanks Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy Diabetes Care 36 2013 631 637
83. JP Kytö, V Harjutsalo, C Forsblom, K Hietala, PA Summanen, PH Groop the FinnDiane Study Group Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes Diabetes Care 34 2011 2005 2007
84. M Lind, AM Svensson, M Kosiborod et al. Glycemic control and excess mortality in type 1 diabetes N Engl J Med 371 2014 1972 1982
85. PH Groop, MC Thomas, JL Moran et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes Diabetes 58 2009 1651 1658
86. TJ Orchard, AM Secrest, RG Miller, T Costacou In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetologia 53 2010 2312 2319
87. RG Miller, AM Secrest, RK Sharma, TJ Songer, TJ Orchard Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort Diabetes 61 2012 2987 2992
88. SJ Livingstone, D Levin, HC Looker et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010 JAMA 313 2015 37 44
89. A Lernmark, HE Larsson Immune therapy in type 1 diabetes mellitus Nat Rev Endocrinol 9 2013 92 103
90. M Knip, HK Åkerblom, D Becker et al. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial JAMA 311 2014 2279 2287
91. BO Roep, TI Tree Immune modulation in humans: implications for type 1 diabetes mellitus Nat Rev Endocrinol 10 2014 229 242
92. E Waters, A de SilvaSanigorski, BJ Burford et al. Interventions for preventing obesity in children Cochrane Database Syst Rev 2013 CD001871.
93. M Savoye, S Caprio, J Dziura et al. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial Diabetes Care 37 2014 317 324
94. R Hovorka Continuous glucose monitoring and closed-loop systems Diabet Med 23 2006 1 12
95. HP Chase, FJ Doyle 3rd, H Zisser et al. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes Diabetes Technol Ther 16 2014 623 632
96. D Elleri, JM Allen, K Kumareswaran et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial Diabetes Care 36 2013 838 844
97. A Haidar, L Legault, V Messier, TM Mitre, C Leroux, R Rabasa-Lhoret Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial Lancet Diabetes Endocrinol 3 2015 17 26
98. BP Kovatchev, E Renard, C Cobelli et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas Diabetes Care 37 2014 1789 1796
99. H Zisser, E Renard, B Kovatchev et al. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites Diabetes Technol Ther 16 2014 613 622
100. SJ Russell, FH El-Khatib, M Sinha et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes N Engl J Med 371 2014 313 325
101. M Phillip, T Battelino, E Atlas et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp N Engl J Med 368 2013 824 833
102. DM Maahs, P Calhoun, BA Buckingham et al. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes Diabetes Care 37 2014 1885 1891
103. L Leelarathna, S Dellweg, JK Mader et al. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study Diabetes Care 37 2014 1931 1937
104. H Thabit, A Lubina-Solomon, M Stadler et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study Lancet Diabetes Endocrinol 2 2014 701 709
105. R Nimri, I Muller, E Atlas et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial Diabetes Care 37 2014 3025 3032
106. B Weber, S Brink ISPAD declaration of Kos Pediatrics 94 1994 A26
107. F Holleman, EA Gale Nice insulins, pity about the evidence Diabetologia 50 2007 1783 1790